Recent studies have demonstrated, both in vitro and in vivo, that the interferon-γ receptor (IFNγR) JAK-STAT signaling pathway is required for T cells to kill cancer cells in solid tumors but not in liquid cancers [15]. This evidence concerns the gene IFNGR1 and cancer.